A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)
         Google Scholar   
Citation:
J Clin Oncol vol 36 (15_suppl) abstr TPS5090
Meeting Instance:
ASCO 2018
Year:
2018
Type:
Abstract
Sub type:
Poster Discussion
Funding:
AFT
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                 
Networks:
ADM400, ADM401, ADM403, ALLIANCE, CA136, CA249, KANSAS, LAB252, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-NY158, MN022, NC012, NH038   
Study
AFT-19
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: